This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Abstract Background/Aims: The rate of healing failure after surgical repair of chronic rotator cuff tears is considerably high. The aim of this study was to investigate the function of the zinc finger transcription factor early growth response 1 (EGR1) in the differentiation of tendon stem cells (TSCs) and in tendon formation, healing, and tendon tear repair using an animal model of rotator cuff repair. Methods: Tenocyte, adipocyte, osteocyte, and chondrocyte differentiation as well as the expression of related genes were determined in EGR1-overexpressing TSCs (EGR1-TSCs) using tissue-specific staining, immunofluorescence staining, quantitative PCR, and western blotting. A rabbit rotator cuff repair model was established, and TSCs and EGR1-TSCs in a fibrin glue carrier were applied onto repair sites. The rabbits were sacrificed 8 weeks after repair operation, and tissues were histologically evaluated and tenocyte-related gene expression was determined. Results: EGR1 induced tenogenic differentiation of TSCs and inhibited non-tenocyte differentiation of TSCs. Furthermore, EGR1 promoted tendon repair in a rabbit model of rotator cuff injury. The BMP12/Smad1/5/8 signaling pathway was involved in EGR1-induced tenogenic differentiation and rotator cuff tendon repair. Conclusion: EGR1 plays a key role in tendon formation, healing, and repair through BMP12/Smad1/5/8 pathway. EGR1-TSCs is a promising treatment for rotator cuff tendon repair surgeries.
Introduction
Tendon retear following rotator cuffs repair surgery is a common problem that has been reported in up to 94% of cases [1] . Various biological approaches have been used to augment surgical repairs to try and improve long-term outcomes of these repair surgeries. These include augmentations with cellular components, extracellular matrix, or various individual growth factors (reviewed in Cheung et al. [1] ). However, sufficient improvements in repair in humans have not yet been reported with any of these approaches, and there is a need for more investigations to identify effective biological augmentation strategies.
Among the various options for supplementing rotor cuff repair surgeries, augmentation with growth factors is considered to be the more attractive procedure. Whereas tendon tissue transplants may induce rejection reactions and extracellular matrix transplants may induce inflammation, augmentation with growth factors is not associated with any of these problems. Furthermore, growth factor augmentations are thought to be technically less complicated [1] . Previous studies have shown that growth factors such as bone morphogenic proteins 2, 7, and 12 (BMP-2, BMP-7, and BMP-12, respectively), transforming growth factors β1 and β3 (TGF-β1 and TGF-β3, respectively), and fibroblast growth factor (FGF) increase healing rates in animal models. However, even though the size of the tendons tended to increase, the improvements in the repairs with these augmentations were questioned since the strength of the repaired tendons did not increase [1] .
The early growth response-1 (EGR1) transcription factor has recently been shown to be involved in tendon differentiation [2] . It was associated with increased collagen formation during tendon cell differentiation in embryo limbs, and it induced expression of the tendon marker scleraxis (SCX) and tendon collagens, including the main tendon collagen Col1a1 [2] . Consistent with the role of EGR1 in tendon differentiation, EGR1
-/-mice exhibited weaker tail tendons compared with wild-type mice [3] .
In a mouse model of Achilles tendon healing, Guerquin and colleagues showed that 1 week after injury, expression of Egr1 as well as tendon-associated markers started to increase (relative to Egr1 expression in mice with intact Achilles tendon), suggesting that the EGR1 protein is involved in healing [3] . In vitro studies further demonstrated a direct role for EGR1 in mesenchymal stem cells (MSC) differentiation into tendon [3] . These same authors also reported that in a rat model for Achilles tendon injury, implanting EGR1-producing MSCs to the repair site resulted in improved formation of tendon-like tissue at the repair site [3] . Although these results show promise for the use of EGR1-producing MSCs in tendon repair, some researchers have suggested that non-tendon derived stem cells have the potential to differentiate into non-targeted tissues and may, therefore, not be the most favorable cells for use in tendon repair [4] .
In the current study we used tendon-derived stem cells (TSCs) to express the EGR1 protein. We hypothesized that EGR1 would drive the differentiation of TSCs into tendon cells and that EGR1-producing TSCs would enhance healing and repair of rotator cuff tears in a rabbit model of this injury.
Materials and Methods

Ethics Statement
Twenty-seven New Zealand white rabbits (8-10 week-old males, 3.5-4.0 kg) were used in the study. All animals were treated according to institutional guidelines for laboratory animal treatment and care. All experimental procedures were approved by the Animal Research Ethics Committee of the Third Military Medical University, China (Approval No. SYXK-PLA-20120031).
Isolation and culture of rabbit TSCs
TSCs were isolated from three New Zealand white rabbits and cultured as described previously [5] . Briefly, patellar tendons were dissected and tissue from the middle tendon portion was harvested. The Gibco, Carlsbad, CA, USA) containing 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine (all from Invitrogen, Carlsbad, CA, USA). Following dilution to different densities, cells were cultured at 37°C in 5% CO 2 . Two days following plating, the cells were washed twice with PBS to remove nonadherent cells. On day 7, they were trypsinized and mixed together as passage 0 cells. Cells from passages 1-3 were used for the following experiments.
Immunofluorescence staining TSCs were immuno-stained as described previously [5] . Briefly, TSCs were fixed in 4% paraformaldehyde/PBS for 30 min. After blocking cells with 2% mouse serum for 1 h at room temperature, they were washed with PBS and incubated at room temperature for 3 h with mouse anti-human primary antibodies (Abcam, Cambridge, MA, USA) against the following stem cell protein markers: octamer-binding transcription factor 4 (Oct-4), stage-specific embryonic antigen-4 (SSEA-4), or nucleostemin. Cells were then washed with PBS and incubated with Cy3-conjugated goat anti-mouse secondary antibody (Abcam) for 30 min at room temperature. Cells were counter stained with DAPI (Sigma-Aldrich), and examined using fluorescence microscopy.
A similar protocol was adopted to perform immuno-staining of the tenogenic proteins tenomodulin (TNMD) and scleraxis (SCX). Goat anti-human TNMD and SCX primary antibodies (Santa Cruz Biotechnology) were used. Secondary antibodies were FITC-conjugated donkey anti-goat IgG (Abcam) or Cy3-conjugated donkey anti-goat IgG antibodies (Abcam).
Plasmid transfection and RNA interference
An EGR1-expressing plasmid was transfected into TSCs as described previously [3] . Briefly, the EGR1 coding sequence from the pCMV-EGR1 cDNA clone (OriGene) was cloned into the pCDNA3.1 + vector (Invitrogen) to yield pCDNA-EGR1. TSCs were transfected with pCDNA-EGR1 or the vector alone (control) using the Lipofectamine 2000 transfection reagent (Invitrogen). G418 (800 μg/ml)-containing medium was used to select stable transfectants. No morphological differences were observed between the TSCs and TSCs transfected with the empty vector. Additionally, differentiation potential and gene expression were not different between these cells, thus TSCs and TSCs transfected with the empty vector were used interchangeably as controls.
For the RNA interference studies, short-hairpin (shRNA) lentiviral particles targeting the BMP12 and Smad1 genes (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used to transfect cells according to the manufacturer's instructions.
Induction of TSCs differentiation
To induce tenogenic differtiation, TSCs and pCDNA-EGR1-transfected TSCs (EGR1-TSCs) were cultured in 6-well plates (2.5×10 5 cells/well) in DMEM (Gibco, Carlsbad, CA, USA) supplemented with 20% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine (all from Invitrogen, Carlsbad, CA, USA) for up to 14 days with medium change every 2 to 3 days. The expression of differentiationrelated genes was determined by immunofluorescence staining and quantitative PCR.
Adipogenic differentiation was induced by incubating TSCs and EGR1-TSCs in adipogenic induction medium (Lonza, Walkersville, MD, USA) for 7 days and in adipogenic maintenance medium for 2-3 days. After 21 days, cells were washed with PBS, fixed in 10% neutral buffered formalin, and stained with Oil Red O for lipid droplets.
Osteogenic differentiation was performed as described previously [6] . Six-well plates containing 3x10 3 cells/cm 2 were incubated in osteogenic induction medium for 28 days, fixed, and stained with Alizarin Red. For chondrgenic differentiation, a pellet culture system, as described by Riu et al. [7, 8] was used. 5x10 5 cells per pellet were incubated in chondrogenic induction medium for 21 days. The pellets were fixed, embedded in paraffin, cut in 5 μm-thick sections, and stained with Toluidine Blue.
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RNA isolation and quantitative real-time PCR (qRT-PCR)
Gene expression was quantified by qRT-PCR. Total RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. The first cDNA strand was synthesized using a Superscript III first-strand synthesis kit (Invitrogen) with oligo (dT) primers in a final volume of 20 μl. qRT-PCR was performed with an ABI 7900 HT system (Applied Biosystems, Foster City, CA, USA) using a QuantiTect SYBR Green RT-PCR kit (Qiagen, Hilden, Germany) [5] . Primers used for qRT-PCR are listed in Table 1 .
Protein extraction and Western blotting
To examine the production of proteins in the BMP12/Smad1/5/8 pathway during tenogenic differentiation, TSCs or EGR1-TSCs were cultured for 0 h, 12 h, 1 d, 3 d, 7 d, and 14 d. Cells were washed twice with PBS and lysed in lysis buffer containing a mixture of proteinase inhibitors (Thermo Fisher Scientific Inc., Rockford, IL, USA). To determine levels of tenocyte-related proteins and those in the BMP12/Smad1/5/8 pathway during tendon healing, tendon tissues were digested in a buffer containing 8 M urea, 50 mM TrisHCl (pH 8), 1mM dithiothreitol, and 1 mM EDTA. Total protein concentrations were measured using a BCA protein assay kit (Thermo Fisher Scientific Inc.), and equal amounts of extracted proteins (30 µg/lane) were resolved by SDS-polyacrylamide gel electrophoresis. Proteins were then transferred on to polyvinylidene difluoride membranes, and membranes blocked by incubating with 5% non-fat milk containing 0.1% TBSTween for 1 h at 20°C. The membranes were then incubated sequentially with primary and secondary antibodies. The following primary antibodies were used: anti-BMP12, anti-phospho-Smad1/5/8, antiSmad, anti-SCX, anti-TNMD, anti-TNC, or anti-Collagen I (all from Santa Cruz Biotechnology). β-actin was used as an internal control. Proteins were visualized and images captured using a LiCoR Odyssey imager (LI-COR Biosciences, Lincoln, NE, USA).
Chronic rotator cuff tear model
The methods described by Chung et al. [9] were used to induce rotator cuff tear in 24 mature New Zealand white male rabbits. The supraspinatus tendon was severed in the right shoulder, and sham operations were performed in the left shoulder (control).
Rotator Cuff Tendon Repair
Six weeks following the induced tear, surgical procedures to repair the injury were performed as described previously [9] . The following procedures were performed in three groups (8 rabbits per group): Group 1 (R), repair surgery; Group 2 (TSCs), repair + TSCs (4x10 6 cells) in a fibrin glue carrier (Baxter AG); and Group 3 (EGR1-TSCs), repair +EGR1-TSCs (4x10 6 cells) in a fibrin glue carrier. Application of TSCs and EGR1-TSCs in a fibrin glue was as described previously [10] . 
Histological analyses and immunohistochemistry
Eight weeks after the repair surgical procedure, all rabbits were sacrificed and a specimen of the greater tubercle of the humeral head with the attached supraspinatus tendon of both shoulders of each rabbit was harvested. Three specimens per group were stored at -80℃ for mRNA extraction for RT-PCR and for protein extraction for Western blotting. The remaining tissue specimens, which included the supraspinatus tendon and greater tuberosity from the repair site, were fixed in neutral buffered 10% formalin (pH 7.4), decalcified, and embedded in paraffin blocks. 5 µm-thick sections were cut in the coronal plane for staining with hematoxylin and eosin (H&E), Masson's Trichrome and for immunohistochemical analysis of collagen I. For immunohistochemical analysis, the sections were immunolabeled with anti-collagen I primary antibodies at 25℃ for 1 h. Isotype-matched negative control antibodies (Zymed) were used under the same conditions. The broad-spectrum immunoperoxidase AEC kit (Picture Plus, Zymed) was used to detect immunoactivity.
Semi-quantitative histomorphometric analyses were performed as described previously [9, 11, 12] . The following scoring system was used: 0 (normal), 1 (slightly abnormal), 2 (moderately abnormal), and 3 (maximally abnormal). Five parameters were semiquantitatively used for scoring: vascularity, cellularity, fiber structure, fiber arrangement, and inflammation rate.
Vascularity (area infiltrated by neo-vascular) was scored 0 for <10% infiltration; 1 for 10-20% infiltration; 2 for 20-30% infiltration; and 3 for > 30% infiltration. Cellularity (rounding of the nuclei) was scored as follows: 0 for long, spindle-shaped cells; 1 for slight rounding; 2 for moderate rounding; and 3 for severe rounding. Fiber structure was scored as: 0 for continuous, long fiber; 1 for slightly fragmented; 2 for moderately fragmented; and 3 for severely fragmented. Fiber arrangement was scored as 0 for compacted and parallel; 1 for slightly loose and wavy; 2 for moderately loose, wavy and cross to each other; and 3 for no identifiable pattern. Inflammation rate (area infiltrated by inflammation cells) was scored as 0 for <10%; 1 for 10-20%, 2 for 20-30%; and 3 for <30%. Based on this scoring system, a perfectly normal tendon would score 0 and a maximally abnormal tendon would score 15.
Statistical Analysis
Data were expressed as mean ± standard deviation (SD). The t-test was used to compare between two groups. Multiple comparisons were made using a one-way analysis of variance followed by Fisher's tests. A p value <0.05 was considered to be statistically significant.
Results
EGR1 induced tenogenic differentiation of TSCs
At passages 3, confluent TSCs isolated from rabbit patellar tendons had the characteristic cobblestone structure of stem cells (Fig. 1A) described previously [5] . Immunofluorescence staining of these TSCs showed they expressed the stem cell marker proteins Oct-4, SSEA-4, and nucleostemin (Fig. 1B, 1C, and 1D, respectively) .
Immunofluorescence staining also showed that the EGR1-overexpressing cells (EGR1-TSCs) had higher levels of the tenocyte-associated protein markers SCX and TNMD compared with TSCs ( Fig. 2A) . The effect of EGR1 on the transcription of tenocyte-associated genes was also examined in the EGR1-TSCs. Over-expression of EGR1 resulted in higher levels of the SCX, TNMD, TNC, and Col I (encoding Collagen I) transcripts (Fig. 2B) , indicating that the effect of EGR1 was at the transcription level of these tenocyte-associated genes.
The specificity of EGR1 in tenocyte differentiation was determined by comparing the histology of TSCs and EGR1-TSCs cultured under adipogenic, osteogenic, and chondrogenic induction conditions. Transcripts for the markers of adipogenesis (PPARγ), osteogenesis (RUNX2), and chondrogenesis (SOX9) were also quantified. Induction of differentiation of the TSCs in the presence of EGR1 overexpression inhibited adipocyte, osteocyte, and chondrocyte differentiation (Fig. 2C) . In addition, PPARγ, RUNX2, and SOX9 transcript levels were lower in the EGR1-TSCs compared with TSC cell (Fig. 2D) , indicating down-regulation of these genes by EGR1. 
TNMD, TNC, and Collagen I transcript levels ( Fig. 3C-3F ) compared with the controls lacking these shRNAs, indicating that BMP12 and Smad1 are expressed upstream of the tenocyteassociated genes.
EGR1 promoted tendon repair and activated BMP/Smad1/5/8 signaling in a rabbit model for rotator cuff injury.
No infections or other complications were observed at the surgical site in any of the animals. The peritendinous fibrous reaction was low in all rabbits. There were no adhesions or contractures limiting the range of motion of the shoulder (data not shown). Eight weeks after the detached supraspinatus tendon in rabbits was surgically repaired in the presence or absence of EGR1-TSCs augmentation, tissues were evaluated histologically and molecularly.
At 8 weeks following surgery, the rotator cuff defects in the R (repair with no augmentation) group were covered with thin fibrous membranes (Fig. 4A) , indicating that the defects in our experimental model did not heal spontaneously. The TSCs group showed parallel fibrous tissues, continuously aligned along the load axis at the tendon insertion with small amounts of Sharpey fibers. In the EGR1-TSCs group, collagen fibers were packed in a parallel pattern, with slight splitting between bundles, and many Sharpey fibers were observed at the tendon insertion site (HE, Fig. 4A ).
Masson trichrome staining showed collagen-fibril formation in the tendon-bone junction during healing (Fig. 4A ). The native tendon had concentrated and orderly collagenfibrils near the tendon-bone junction, whereas the R group had loose collagen-fibrils at the tendon-bone junction and in the tendon. The TSCs group had concentrated collagen-fibrils at the tendon-bone interface near the tendon, and the EGR1-TSCs group had higher collagenfibril expression with some orderly pattern (Fig. 4A) .
The mean composite histology scores showed that the repair in the presence of EGRTSCs had better outcome than either repair in the presence of TSCs alone or in the absence of any augmentation (R, Fig. 4B ).
Immunohistochemical analysis of repaired tendons showed greatly enhanced staining of Type I collagen protein in the EGR1-TSCs group compared with other groups. (Fig. 5A) . 
Discussion
In the current study we showed that in a rabbit model of rotator cuff injury, surgical repair of tendon tear in the presence of EGR1-overexpressing TSCs heals better than repairs performed with implants of TSCs only or with no implants. These results were supported by our in vitro studies, which showed that EGR1 induces specific differentiation of TSCs into tenocytes. EGR1 production in these cells also induced the expression of tendon marker genes SCX, TNMD, TNC, and Collagen1 both in vitro and in vivo.
Our study extends previous works that had demonstrated that EGR1 drives differentiation of MSCs into tendon-lineage [3] . These studies had also shown that implants with EGR1-expressing MSCs improved repair of tendon tears in the rat model of Achilles tendon injury [3] .
A study using a rat model of rotator cuff healing had previously shown that animals receiving MSCs producing SCX had better healing compared with those receiving MSCs alone [10] . In that study, tissues repaired in the presence of SCX-producing cells had higher stress- to-failure and stiffness values compared with tissues repaired in the absence of the SCXproducing MSCs. Our study showed that SCX levels increased in EGR1 overexpressing cells. Given that EGR1 acts upstream of SCX in the signaling pathway and that it increases SCX as well as other tendon-specific proteins, we would expect similarly improved tendon tissue healing in our rabbit model of rotator cuff repair. However, this will have to be confirmed in additional studies evaluating the biomechanical properties of the regenerated tissue. Although MSCs have been reported to show promising outcomes for tendon repair, transplantation of these stem cells in tendon repair has also been reported to result in ectopic bone and tumor formation [15, 16, 17] . Thus, stem cells with increased propensity for tendon formation would provide a better option for tendon tear repairs. Liu et al. reported that stem cells derived from tendon tissues may have more advantages (in tendon repair) than stem cells from other sites since the tendon milieu these cells are harvested from may predispose them to tendon generation and to greater potential for expressing tendon-specific markers such as SCX and TNMD [18] . Thus, TSCs may be a better and safer alternative for EGR1 overexpression in tendon repair as they have been reported to have a predisposition to tendon formation [4, 15] . Additionally, TSCs have been reported to have higher clonogenicity and proliferation rates compared with bone marrow stem cells, and this could aid better healing [18] .
Finally, consistent with previous studies, we showed that EGR1 induces the BMP12/ Smad1/5/8 pathway during tendon differentiation in vitro and during tendon tear healing in vivo. The current study, nevertheless, has some limitations. First, it was limited by the difficulty of replicating human disease in an animal model, and our results should be interpreted with caution regarding clinical application, because of the differences in the anatomy of the shoulder and the intrinsic healing potential between rabbits and humans. Second, we did not track the TSCs and EGR1 expression in vivo and thus cannot be entirely certain that the TSCs stayed in the desired site and that these cells overexpressed EGR1. However, expression of EGR1 by transduced TSCs was confirmed with RT-PCR and Western blotting in vitro. Since the TSCs and EGR1-TSCs-treated groups showed a significant effect on tendon-bone healing in this study, we believe that TSCs were present at the repair site and that these cells overexpressed EGR1. Future studies to track the EGR1-TSCs after injection using labeled cells still need to clarify their differentiation status and potential contribution to tendon healing. Finally, we studied the status of tendon-to-bone healing only at a midterm period until 8 weeks after repair and had no information on further changes at a later postoperative period. We selected 8 weeks based on previous studies [9, 19] , but there certainly could be more mechanical and biological changes after 8 weeks. Therefore further study with a longer postoperative observation period may be needed.
In conclusion, our studies demonstrated that EGR1-TSCs could be useful for augmenting rotator cuff tendon repair surgeries. Additional studies are required to evaluate the longterm quality of these tendon repairs.
